We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$15.1B
AUM Growth
-$1.32B
Cap. Flow
-$1.84B
Cap. Flow %
-12.19%
Top 10 Hldgs %
6.07%
Holding
4,629
New
783
Increased
1,169
Reduced
1,303
Closed
1,222

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$66.7M
2
MSCI icon
MSCI
MSCI
+$54.1M
3
BMY icon
Bristol-Myers Squibb
BMY
+$46.5M
4
RMD icon
ResMed
RMD
+$44.7M
5
PPG icon
PPG Industries
PPG
+$43.3M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$74M
2
LHX icon
L3Harris
LHX
+$69.6M
3
HON icon
Honeywell
HON
+$64.1M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$60.2M
5
WFC icon
Wells Fargo
WFC
+$59.2M

Sector Composition

Rank Sector Weight
1 Technology 11.88%
2 Consumer Discretionary 8.49%
3 Financials 8.33%
4 Industrials 8.18%
5 Healthcare 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICU icon
3301
SeaStar Medical
ICU
$14.7M
$5.46K ﹤0.01%
+42
New +$12.6K
LFACW
3302
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
$5.36K ﹤0.01%
97,531
+912
+0.9% +$54
ALZN icon
3303
Alzamend Neuro
ALZN
$7M
$5.36K ﹤0.01%
8
-4
-33% -$3.13K
AVGO icon
3304
Broadcom
AVGO
$2.01T
$5.21K ﹤0.01%
60
-56,460
-100% -$4.03M
GYRE icon
3305
Gyre Therapeutics
GYRE
$713M
$5.16K ﹤0.01%
+979
New +$3.51K
ACDC icon
3306
ProFrac Holding
ACDC
$929M
$5.16K ﹤0.01%
462
-57,699
-99% -$683K
BHACW
3307
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$5.11K ﹤0.01%
245,431
MITAW
3308
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$5.07K ﹤0.01%
33,842
MMS icon
3309
Maximus
MMS
$2.9B
$5.07K ﹤0.01%
60
-9,452
-99% -$777K
OMIC
3310
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$5.06K ﹤0.01%
+203
New +$5.95K
VBOCW
3311
DELISTED
Viscogliosi Brothers Acquisition Corp Warrant
VBOCW
$5.04K ﹤0.01%
146,654
SAMAW
3312
DELISTED
Schultze Special Purpose Acquisition Corp. II Warrant
SAMAW
$4.97K ﹤0.01%
121,273
VWE
3313
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$4.92K ﹤0.01%
+5,751
New +$6.68K
CRKN
3314
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
QDROW
3315
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$4.84K ﹤0.01%
72,105
AONCW
3316
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$4.81K ﹤0.01%
31,173
-100
-0.3% -$8
GTACW
3317
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$4.78K ﹤0.01%
68,793
ASTI icon
3318
Ascent Solar Technologies
ASTI
$34.5M
$4.74K ﹤0.01%
+2
New +$8.32K
HCM icon
3319
HUTCHMED
HCM
$2.18B
$4.72K ﹤0.01%
393
-25,214
-98% -$344K
NIXX
3320
Nixxy Inc
NIXX
$15.9M
$4.53K ﹤0.01%
+1,239
New +$4.43K
WE
3321
DELISTED
WeWork Inc.
WE
$4.5K ﹤0.01%
440
-5,166
-92% -$71.5K
NUBIW
3322
DELISTED
Nubia Brand International Corp. Warrant
NUBIW
$4.36K ﹤0.01%
55,072
NOVN
3323
DELISTED
Novan, Inc. Common Stock
NOVN
$4.34K ﹤0.01%
+10,105
New +$10.7K
SHUAW
3324
DELISTED
SHUAA Partners Acquisition Corp I Warrant
SHUAW
$4.3K ﹤0.01%
74,875
IRNT
3325
DELISTED
IronNet, Inc.
IRNT
$4.26K ﹤0.01%
+20,423
New +$5.06K

Similar funds

Cubist Systematic Strategies's Q2 2023 Portfolio in Review

As of Q2 2023, Cubist Systematic Strategies held 4,629 positions worth $15.1B, down 8.1% from $16.4B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Cubist Systematic Strategies withdrew a net $1.84B in Q2 2023, closing 1,222 positions and reducing 1,303 holdings. Its most notable exit was Cigna, an estimated $74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Cubist Systematic Strategies opened a new position in Atlassian worth $34.2M.

  • Cubist Systematic Strategies's largest Q2 2023 buy was Atlassian: 203,897 shares worth $34.2M.
  • Cubist Systematic Strategies added most to Alphabet (Google) Class A in Q2 2023, an estimated $66.7M increase.
  • Cubist Systematic Strategies's biggest Q2 2023 reduction was L3Harris, cutting an estimated $69.6M.
  • Cubist Systematic Strategies fully exited Cigna in Q2 2023, selling an estimated $74M.
  • Cubist Systematic Strategies's ten largest holdings make up 6.1% of its $15.1B portfolio in Q2 2023.
  • Cubist Systematic Strategies opened 783 new positions and closed 1,222 in Q2 2023.
  • Cubist Systematic Strategies's portfolio value fell 8.1% quarter-over-quarter to $15.1B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.